01-Dec-2016 - Carl Zeiss AG

ZEISS and EPFL begin long-term research collaboration

ZEISS will support innovative research projects at the Swiss Federal Institute of Technology in Lausanne (École polytechnique fédérale de Lausanne, abbr. EPFL). The company will make one million euros available for new research projects in key technology fields such as biomedical research, medical diagnostics and visualization as well as optical metrology and inspection. This is part of a partnership with the renowned EPFL which will take the existing connections between the company and the university to a whole new level. Starting in 2017 ZEISS will also present student awards at the university to honor innovative master's and doctoral theses in the areas of photonics, optoelectronics, computational imaging and data analysis.

Today Prof. Patrick Aebischer, President of the EPFL, and Dr. Ulrich Simon, Head of Corporate Research and Technology at ZEISS, will sign the framework agreement for this long-term collaboration.
"This contract spans several years and will enable more agile and dynamic collaboration than with the traditional collaborative projects between academia and industry," says Dr. Ulrich Simon. "We have defined key research areas and are giving the university free reign in its research. By working together we will achieve new insights and want to more strongly support innovations."

Prof. Patrick Aebischer adds: „EPFL has state-of-the-art laboratories capable of providing innovative solutions in areas such as biomedical research, medical diagnostics, visualization and optical metrology which are of particular interest to ZEISS.“

Important goals of the collaboration

Thanks to the support from ZEISS, new research projects can be initiated and developed. Both parties want to launch and foster innovative projects together. The focus of the collaboration is on key technologies such as multidimensional imaging and data processing, multidimensional visualization, human-machine interaction and intelligent automation. A joint scientific committee will steer and oversee the projects.

This committee will also organize and present the ZEISS student awards for outstanding student research in photonics, optoelectronics, computational imaging and data analysis. Each winner will receive 3,000 Swiss francs (approx. 2,800 euros) for a dissertation and 1,500 Swiss francs (approx. 1,400 euros) for a master's thesis. Moreover, the three finalists in each category will also be invited to visit the ZEISS site in Oberkochen for a day.

Within the scope of the partnership, the relationships between researchers, students and employees will be taken to new heights through workshops and other forms of direct contact. This collaboration furthers the goal of the EPFL to closely link teaching and research with international companies such as Nestlé, IBM and Logitech. It also continues the ZEISS tradition of advancing leading innovations through close collaboration, especially with academic institutions.

Facts, background information, dossiers
  • EPFL
  • imaging
  • optoelectronics
More about Carl Zeiss
  • News

    Tenth Record-Breaking Year in a Row for ZEISS

    The ZEISS Group continued its growth trajectory, with revenue and earnings reaching new heights in fiscal year 2018/19, which ended 30 September 2019. Revenue grew by 11 percent, reaching 6.428 billion euros (previous year: 5.817 billion euros). Adjusted for currency and acquisition effects ... more

    ZEISS and Senorics Establish Partnership

    ZEISS’ investment in Senorics marks the start of a technology collaboration with the sensorics startup based in Dresden, Germany. The partnership aims to further the joint development of small and cost-effective sensors for industrial use in quality assurance and in process monitoring, e.g. ... more

    ZEISS Opts for Continuity with New CEO

    At its meeting on 24 September 2019, the Supervisory Board of Carl Zeiss AG unanimously voted in favor of the following changes to the Executive Board: Dr. Karl Lamprecht, currently a Member of the Executive Board, will become the new President & CEO effective 1 April 2020. With this appoin ... more

  • Companies

    Carl Zeiss Vision GmbH

    Having been founded in 2005, Carl Zeiss Vision is the new leader in ophthalmic products. We provide the consumer and the eyecare professional with quality spectacle lenses, diagnostic tools, services and support in business and marketing. more

    Carl Zeiss AG

    Carl Zeiss AG is a leading group of companies operating worldwide in the optical and opto-electronic industry. The five independently operating business groups are active in the future-oriented markets of Medical and Research Solutions, Industrial Solutions and Lifestyle Products. Founded i ... more

    Carl Zeiss Jena GmbH

    Carl Zeiss designs and manufactures spectral sensors from 0.9-2.2 µm. We also deliver On-line, At-line and In-Line spectrometer systems for concentration, layer thickness and colour measurement. Specially configurations for pharma and food industry. more

More about Ecole Polytechnique Fédérale de Lausanne
  • News

    Emergence of calorie burning fat cells

    1.9 billion people in the world are overweight. Of these, 650 million people are obese, which increases the risk of secondary diseases such as high blood pressure or cancer. Professor Martin Klingenspor and his team at the Technical University of Munich (TUM) examine how our fat metabolism ... more

    Predicting a protein's behavior from its appearance

    Proteins are the building blocks of life and play a key role in all biological processes. Understanding how they interact with their environment is therefore vital to developing effective therapeutics and the foundation for designing artificial cells. Researchers at the Laboratory of Protei ... more

    On the way to nanotheranostics

    Theranostics is an emerging field of medicine whose name is a combination of "therapeutics" and "diagnostics". The idea behind theranostics is to combine drugs and/or techniques to simultaneously - or sequentially - diagnose and treat medical conditions, and also monitor the response of the ... more

  • Videos

    The Gates of Serotonin

    EPFL scientists have elucidated for the first time how a notoriously elusive serotonin receptor functions with atom-level detail. The receptor transmits electrical signals in neurons and is involved in various disorders, meaning that the discovery opens the way for new treatments. The recep ... more